The front door should be as credible as the medicine.
AnthologyRX was built by patients, operators, clinicians, and coaches who wanted serious treatments to be matched by a clear, trustworthy way to begin.
Access only matters when judgment comes with it.
Information is easy to find. Products are easy to find. The harder thing is a system that can tell you what fits your case, what does not, and who remains accountable after a prescription is written.
AnthologyRX brings that judgment to a broad prescription catalogue across metabolic health, hormones, sexual health, hair and skin, longevity, recovery, and supportive care. AnthologyRX+ goes deeper into peptide and performance medicine for the patient who already knows the category and wants a more credible path through it.
Different storefronts, same standard: a medical decision before a transaction.
Four disciplines. One standard.
The founding team came to AnthologyRX from company building, revenue, medicine, and human performance. Each saw the same gap from a different angle. People were already seeking these treatments. The experience around them had not earned the same level of trust.
Michael Eisman builds companies in categories that do not come with a playbook. At Apple, he learned what operational precision looks like at scale. At MedMen, he helped architect the nationally recognized retail brand described in the press as "the Apple Store of Weed," raised $150 million, and helped make an emerging category understandable to mainstream customers. He later took on a distressed B2B logistics company, cleared $2 million in inherited debt, rebuilt the operation, and exited at 8x EBITDA.
He went on to found Echelon Agency in Los Angeles, a talent-management firm at the intersection of elite fitness and the creator economy. There, he saw a pattern early. High-performing people were already using clinical longevity treatments to sustain the work, but the category lacked a credible consumer experience around the medicine.
Michael is also a patient of the treatments AnthologyRX offers. The company began with a lived standard: build the access, clarity, and accountability he wanted for himself.
Danika Lane Wignall has spent a decade earning trust in complex B2B environments. As National Director of Sales and later VP of Sales and Marketing at Pegasus, she built and led revenue operations serving pharmaceutical manufacturers, biotechnology laboratories, and aerospace companies, where details matter and long sales cycles test every claim.
Before Pegasus, she closed complex, multiyear contracts at Controlled Contamination Services across Los Angeles, the Inland Empire, and Orange County. The work sharpened the instincts this category demands: listen closely, make the value legible, and build a relationship strong enough to hold a high-consideration decision.
As Chief Revenue Officer, Danika leads the partnerships, patient-acquisition systems, and commercial infrastructure that turn a serious care model into a company people can find and trust.
Dr. Dylan Russell graduated from West Point with a degree in Life Sciences and Chemistry, earned his MD from the University of Virginia School of Medicine, and completed seven years of surgical residency with the United States Army. He serves as a General Surgeon with the U.S. Army Medical Department.
Military medicine gave him a direct view of what happens when metabolic decline is addressed late. His commitment to prevention comes from that clinical reality. Serious medicine does not begin only when the damage becomes urgent.
As Chief Health Officer, Dr. Russell sets the medical standard used to evaluate the catalogue. The question is the same one he would ask for any patient, including himself: does this treatment belong in this case, and can the decision be defended clinically?
Dave Schenk has spent more than two decades studying and coaching human performance. He was a Division I wrestler at Cal Poly San Luis Obispo, team captain, and conference champion at 197 pounds. He later built and operated performance facilities across Southern California, earned credentials from ACE, NASM, and the National Strength and Conditioning Association, became a Certified Strength and Conditioning Specialist, presented internationally at ASIAFIT in Shanghai, and founded Iron Anthology in Los Angeles.
Twenty years of coaching makes change hard to ignore. Hormonal output shifts. Recovery takes longer. A plan that worked at 30 may need a different level of support at 45. Dave approached clinical longevity medicine the same way he approached training: methodically, with a standard that every claim should survive scrutiny.
As Chief Brand Officer, he makes that standard visible in how AnthologyRX speaks, teaches, and earns attention.
Independent licensed providers review the Assessment, medical history, current medications, and the treatment being considered. AnthologyRX builds the platform and care-coordination experience around that relationship. It does not make the prescribing decision. Some catalogue medications are FDA-approved finished drug products. Others are compounded to individual prescriptions by licensed pharmacies and are not FDA-approved finished drug products. The depth and type of evidence also vary by treatment. Those differences belong in the decision, stated plainly, with a clinician responsible for what they mean in your case. Clinical credibility is not a layer added after the brand. It is the standard the brand is built to serve.
"You can buy longevity and performance treatments anywhere.
At Anthology, you're buying the will to aspire to your true potential."
Michael Eisman, Chief Executive Officer
Start with a real clinical review.
Complete the Assessment in about 10 minutes. A licensed provider typically reviews it in under 24 hours. If approved, the prescription moves to the appropriate licensed pharmacy. If not approved, you are not charged.